Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Lingzhi (Ganoderma lucidum, also known as Reishi mushroom) has a long history of use in traditional Chinese medicine (TCM) for supporting respiratory health, including symptoms that overlap with chronic obstructive pulmonary disease (COPD). In TCM, Lingzhi is valued for its purported abilities to "nourish the lungs," reduce phlegm, and enhance overall vitality. Historical texts and herbal compendia frequently mention its use for chronic cough, asthma, and breathlessness—symptoms commonly seen in COPD. These traditional uses form the primary basis for Lingzhi's application to COPD-like conditions.

Modern scientific evidence for Lingzhi’s effectiveness specifically for COPD remains limited and preliminary. Some laboratory and animal studies suggest that Ganoderma lucidum extracts may exhibit anti-inflammatory, immunomodulatory, and antioxidant effects, which could theoretically benefit COPD—a disease characterized by chronic airway inflammation and oxidative stress. A few small clinical studies in humans have explored its effects on general lung function or quality of life in chronic respiratory diseases, but these are limited by small sample sizes and methodological weaknesses. No large, high-quality randomized controlled trials have yet established Lingzhi as an effective or standard therapy for COPD.

In summary, the use of Lingzhi for COPD is justified primarily by tradition, with limited and low-quality scientific evidence to date. It should not replace standard COPD therapies, but may be used as a complementary approach in consultation with a healthcare provider.

More about lingzhi
More about Chronic Obstructive Pulmonary Disorder

Other ingredients used for Chronic Obstructive Pulmonary Disorder

Other health conditions supported by lingzhi

Products containing lingzhi